In this interview Richard Liew speaks to Julie Jones, founder and CEO at new biotech contract research organisation, BioValeo.
In a discussion filled with insights for biotech founders, Julie explains the rigorous clinical trials and regulations required for bringing a new medicine or medical device to market, and touches on other key challenges for NZ biotechs.
We also hear how BioValeo hopes to help more Kiwi biotechs exploring exciting treatments including cancer fighting CAR T-cell therapies.
WATCH NOW:
